Target intelligence / Profile preview

Cysteine residue in protein

Molecular classification
Other
01

Overview

Cysteine residues are the sulfur-containing amino acid building blocks present within proteins. They are unique due to their thiol (-SH) side chain, which is chemically reactive and can undergo various post-translational modifications, including oxidation to form disulfide bonds (cystine), S-glutathionylation, S-nitrosylation, and conjugation with metals (as seen in zinc fingers)[1][2][4][5][6]. Disulfide bonds formed between cysteine residues greatly stabilize protein tertiary and quaternary structures in the oxidizing extracellular environment, contribute to protein rigidity, and can be essential for biological activity[1][3][4][5]. Cysteine's thiol group also acts as a nucleophile in many enzyme active sites (such as proteases, oxidoreductases), making such cysteines targets for regulation by redox changes or for covalent inhibition by some drugs[2][6][7]. Post-translational modifications of cysteine are major mediators of redox-sensing and signal transduction, especially in response to oxidative stress[6][7]. These modifications can reversibly or irreversibly alter protein function, and dysregulation is implicated in diseases such as diabetes, cancer, and neurodegeneration[2][6]. Cysteine residues themselves, however, are not considered a drug target; instead, specific proteins containing catalytically or structurally important cysteines can be, making “cysteine residues in proteins” an incorrect designation for a canonical therapeutic target.

Other names
Cys residueprotein cysteinecysteinyl residue
02

Mechanism of action

Covalent modification of cysteine thiols (inhibition or activation of enzyme activity) - Disulfide bond reduction/oxidation - Alteration of redox signaling

03

Biological functions

Structural stabilization (disulfide bonding)Redox regulationMetal ion bindingCatalysis (in enzyme active sites)Signal transduction
04

Disease associations

CancerNeurodegenerative diseaseDiabetesInflammationOther (dependent on specific protein context)
05

Safety considerations

Off-target modification of cysteine residues leads to toxicityDisruption of protein folding and stabilityOxidative stress from indiscriminate cysteine oxidation
06

Interacting drugs

Drugs targeting cysteine proteases (e.g., E-64, leupeptin)

2 more in the full profile.

07

Biomarkers

Protein S-glutathionylation as a marker of oxidative stressS-nitrosylation of protein cysteinesRedox status of specific cysteine residues in signaling proteins (e.g., peroxiredoxins, thioredoxins)

Beyond the preview

Go deeper on Cysteine residue in protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine residue in protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call